Centro de Investigacións Científicas Avanzadas (CICA), Departamento de Química, Facultade de Ciencias, Universidade da Coruña, Coruña, 15071 A, Spain; Grupo GIBE, Departamento de Bioloxía, Centro de Investigacións Científicas Avanzadas (CICA), Universidade da Coruña, Coruña, 15071 A, Spain.
Departamento de Microbioloxía e Parasitoloxía, Instituto de Acuicultura, Universidade de Santiago de Compostela, Santiago de Compostela, 15782, Spain.
Fish Shellfish Immunol. 2019 Nov;94:723-729. doi: 10.1016/j.fsi.2019.09.066. Epub 2019 Sep 30.
Photobacteriosis caused by Photobacterium damselae subsp. piscicida (Pdp) remains one of the main infectious diseases affecting cultured fish in Mediterranean countries. Diverse vaccine formulations based in the use of inactivated bacterial cells have been used with unsatisfactory results, especially in newly cultured species like sole (Solea senegalensis). In this work, we describe the use of the outer membrane receptor (FrpA) of the siderophore piscibactin produced by Pdp as a novel subunit vaccine against photobacteriosis. FrpA has been cloned and expressed in Escherichia coli under an arabinose-inducible promoter. A recombinant protein (rFrpA) containing the pelB localization signal and a His tag was constructed to obtain a pure native form of the protein from E. coli outer membranes. The immunogenicity of rFrpA, and its protective effect against photobacteriosis, was tested by i.p. injection of 30 μg of the protein, mixed with Freund's adjuvant, in sole fingerlings with two immunizations separated by 30 days. Results showed that using either pure rFrpA or whole cells as immobilized antigens in ELISA assays, rFrpA induces the production of specific antibodies in sole. An experimental infection using fish vaccinated with rFrpA or formalin-killed whole cells of Pdp showed that both groups were protected against Pdp infection at similar levels, with no significant differences, reaching RPS values of 73% and 79%, respectively. Thus, FrpA constitutes a promising antigen candidate for the development of novel more effective vaccines against fish photobacteriosis.
由鱼类发光杆菌亚种(Pdp)引起的发光杆菌病仍然是影响地中海国家养殖鱼类的主要传染病之一。已经使用了多种基于灭活细菌细胞的疫苗制剂,但效果并不理想,尤其是在像欧鳎(Solea senegalensis)这样的新养殖物种中。在这项工作中,我们描述了使用鱼类发光杆菌产生的铁载体鱼宝素的外膜受体(FrpA)作为一种针对发光杆菌病的新型亚单位疫苗。FrpA 已在大肠杆菌中使用阿拉伯糖诱导型启动子进行克隆和表达。构建了含有 pelB 定位信号和 His 标签的重组蛋白(rFrpA),以从大肠杆菌外膜中获得纯天然形式的蛋白质。通过腹腔注射 30 μg 与弗氏佐剂混合的 rFrpA,在欧鳎鱼苗中进行了两次免疫,间隔 30 天,测试了 rFrpA 的免疫原性及其对发光杆菌病的保护作用。结果表明,使用纯 rFrpA 或整个细胞作为 ELISA 检测中的固定抗原,rFrpA 可诱导欧鳎产生特异性抗体。使用 rFrpA 或福尔马林杀死的 Pdp 全细胞对鱼进行实验性感染表明,两组的保护水平相似,没有显著差异,分别达到 73%和 79%的 RPS 值。因此,FrpA 构成了开发针对鱼类发光杆菌病的新型更有效疫苗的有前途的抗原候选物。